Future Directions for Dementia Risk Reduction and Prevention Research: An International Research Network on Dementia Prevention Consensus
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
In the past decade a large body of evidence has accumulated on risk factors for dementia, primarily from Europe and North America. Drawing on recent integrative reviews and a consensus workshop, the International Research Network on Dementia Prevention developed a consensus statement on priorities for future research. Significant gaps in geographical location, representativeness, diversity, duration, mechanisms, and research on combinations of risk factors were identified. Future research to inform dementia risk reduction should fill gaps in the evidence base, take a life-course, multi-domain approach, and inform population health approaches that improve the brain-health of whole communities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Schematic Birdseye View of the Current Landscape of Evidence for Dementia Risk Reduction Research. Note. This heatmap is indicative of the evidence that is currently available from systematic reviews and meta-analyses of dementia risk reduction research. Evidence was collated from a number of large-scale reviews [17–20] and influenced by [13–16, 46, 47].](https://figures.cochat.ai/paper-figures/ddeb41d2653341a4a82c61e2968f5abc/future-directions-for-dementia-risk-reduction-and-prevention-research-an-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ADRD research focuses heavily on mid-life to late life (>40 years), and to some extent on childhood (<18 years).7 Less attention has been given to the life period in between: young adulthood.8”
From Next generation brain health: transforming global research and public health to promote prevention of dementia and reduce its risk in young adult populations (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The network described the inadequate evidence on public knowledge about dementia prevention—particularly with respect to the more detailed investigation of differences between population subgroups—as a crucial deficit in dementia research. In addition, they describe a lack of knowledge transfer and prevention programs that could contribute to the promotion of (brain-)healthier lifestyles at both”
From Sociodemographic differences in dementia prevention knowledge in Germany: Implications for targeted health communication (2026) · cites this paper as [17]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Substantial knowledge gaps remain about how exposure to modifiable factors in young adulthood affect ADRD outcomes.”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“To date, the influence of sociodemographic factors on knowledge about dementia prevention has not been sufficiently examined, particularly in Germany, leaving a critical gap for targeted public health strategies.”
From Sociodemographic differences in dementia prevention knowledge in Germany: Implications for targeted health communication (2026) · cites this paper as [17]
Experimental — accuracy not yet measuredIn the citing paper
“A 2020 data mapping of recognised factors found little to no ADRD research on hearing loss, depression, obesity, inactivity, alcohol, and social isolation in young populations (aged <30 years).7”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072 · cited 2×
“Early work by committee members [13, 14] and other recent reports such as the Lancet Commission [15] concluded that childhood education, exercise, maintaining social engagement, reducing smoking, and management of hearing loss, depression, diabetes, and obesity across the life course are key protective factors which c…”
BackgroundThe projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,666
Self-citationPotential for primary prevention of Alzheimer's disease: an analysis of population-based data
Norton, S., Matthews, F. E., Barnes, D. E., Yaffe, K., & Brayne, C. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70136-x · Cited by 2,466 · cited 1×
“Early work by committee members [13, 14] and other recent reports such as the Lancet Commission [15] concluded that childhood education, exercise, maintaining social engagement, reducing smoking, and management of hearing loss, depression, diabetes, and obesity across the life course are key protective factors which c…”
BackgroundSelf-citationLautenschlager, N. T., Cox, K. L., Flicker, L., Foster, J. K., van Bockxmeer, F. M., Xiao, J., Greenop, K. R., & Almeida, O. P. (2008) · JAMA · doi:10.1001/jama.300.9.1027 · Cited by 1,637 · cited 1×
“An example is seen with exercise interventions (for adults with insufficient levels of physical activity) that result in cognitive improvement [32] but such examples need to be extended to establish reduction in dementia incidence in large samples.”
BackgroundSelf-citationLimbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Nelson, P. T., Dickson, D. W., Trojanowski, J. Q., Jack, C. R., Boyle, P. A., Arfanakis, K., Rademakers, R., Alafuzoff, I., Attems, J., Brayne, C., et al. (2019) · Brain · doi:10.1093/brain/awz099 · Cited by 1,547 · cited 1×
“This means that alternative methods, such as case-control studies, large-scale register-based studies, and data pooling, may be required to obtain better information on risk factors associated with dementias such as frontotemporal [42], Lewy body dementia [43], limbic-predominant age-related TDP-43 encephalopathy [44]…”
MethodSelf-citationWilliamson (2019) · doi:10.1001/jama.2018.21442 · Cited by 1,246
Incidence of dementia over three decades in the Framingham heart study
Satizabal, C. L., Beiser, A. S., Chouraki, V., Chêne, G., Dufouil, C., & Seshadri, S. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1504327 · Cited by 1,051 · cited 1×
“Although reports of a reduction in incidence in some high-income countries are promising [2, 3], prevalence will continue to increase overall due to population aging (e.”
BackgroundSex differences in Alzheimer disease — the gateway to precision medicine
for the Women’s Brain Project and the Alzheimer Precision Medicine Initiative, Ferretti, M. T., Iulita, M. F., Cavedo, E., Chiesa, P. A., Schumacher Dimech, A., Santuccione Chadha, A., Baracchi, F., Girouard, H., Misoch, S., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0032-9 · Cited by 1,009 · cited 1×
“The field is increasingly aware of the need to evaluate risk profiles stratified by sex and gender to inform sex and gender-based risk reduction strategies [28].”
BackgroundEpidemiology of Obesity and Diabetes and Their Cardiovascular Complications
Bhupathiraju, S. N., & Hu, F. B. (2016) · Circulation Research · doi:10.1161/circresaha.115.306825 · Cited by 945
The epidemiology of frontotemporal dementia
Onyike, C. U., & Diehl-Schmid, J. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.776523 · Cited by 543
Babulal, G. M., Quiroz, Y. T., Albensi, B. C., Arenaza‐Urquijo, E., Astell, A. J., Babiloni, C., Bahar‐Fuchs, A., Bell, J., Bowman, G. L., Brickman, A. M., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.09.009 · Cited by 528 · cited 2×
“Within countries and cohort studies it is possible that risk exposure, risk effects and protective mechanisms (e.g., cognitive resilience, cognitive reserve, coping mechanisms and strategies) vary within subgroups (e.g., indigenous populations in Australia [24], Canada and United States [25]; racial minorities in the…”
BackgroundSelf-citationStern, Y., Barnes, C. A., Grady, C., Jones, R. N., & Raz, N. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.03.022 · Cited by 514 · cited 1×
“The field would benefit from consensus regarding conceptual and operational definitions of reserve, resilience and related constructs, and clarification of their neurobiological substrates [37].”
BackgroundA two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II
Matthews, F. E., Stephan, B. C. M., Robinson, L., Jagger, C., Barnes, L. E., Arthur, A., Brayne, C., Cognitive Function and Ageing Studies (CFAS) Collaboration, Comas-Herrera, A., Wittenberg, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11398 · Cited by 426
Self-citationConceptual and Measurement Challenges in Research on Cognitive Reserve
Jones, R. N., Manly, J., Glymour, M. M., Rentz, D. M., Jefferson, A. L., & Stern, Y. (2011) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617710001748 · Cited by 363 · cited 1×
“While cognitive reserve has long been identified in the literature to explain the impact of factors such as education and enriched environments on brain development, the neurobiological factors underpinning reserve and mechanisms to build reserve in the population, are not understood [34, 35].”
BackgroundPrimary Progressive Aphasia: Longitudinal Course, Neuropsychological Profile, and Language Features
Weintraub, S. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120075013 · Cited by 310
Bateman, R. J., Benzinger, T. L., Berry, S., Clifford, D. B., Duggan, C., Fagan, A. M., Fanning, K., Farlow, M. R., Hassenstab, J., McDade, E. M., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.07.005 · Cited by 303 · cited 2×
“, DIAN [46]), there is also a need to determine the extent to which younger onset dementias could be delayed by risk modification, (e.”
BackgroundYou, W.-P., & Henneberg, M. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000161 · Cited by 257
Licher, S., Ahmad, S., Karamujić-Čomić, H., Voortman, T., Leening, M. J. G., Ikram, M. A., & Ikram, M. K. (2019) · Nature Medicine · doi:10.1038/s41591-019-0547-7 · Cited by 233 · cited 1×
“, body mass index [21]) and genetic predisposition [22].”
BackgroundFreedland, K. E., King, A. C., Ambrosius, W. T., Mayo-Wilson, E., Mohr, D. C., Czajkowski, S. M., Thabane, L., Collins, L. M., Rebok, G. W., Treweek, S. P., et al. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.02.011 · Cited by 218
Anstey, K. J., Ee, N., Eramudugolla, R., Jagger, C., & Peters, R. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190181 · Cited by 187 · cited 4×
“Members of IRNDP also performed a systematic review of meta-analyses of all observational studies on risk factors for dementia [18].”
BackgroundMethodInfluentialSelf-citationExploring the Neural Basis of Cognitive Reserve
Stern, Y., Zarahn, E., Hilton, H. J., Flynn, J., DeLaPaz, R., & Rakitin, B. (2003) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/jcen.25.5.691.14573 · Cited by 168 · cited 1×
“While cognitive reserve has long been identified in the literature to explain the impact of factors such as education and enriched environments on brain development, the neurobiological factors underpinning reserve and mechanisms to build reserve in the population, are not understood [34, 35].”
BackgroundA multiomics approach to heterogeneity in Alzheimer’s disease: focused review and roadmap
Badhwar, A., McFall, G. P., Sapkota, S., Black, S. E., Chertkow, H., Duchesne, S., Masellis, M., Li, L., Dixon, R. A., & Bellec, P. (2020) · Brain · doi:10.1093/brain/awz384 · Cited by 165
Self-citationConcepts for brain aging: resistance, resilience, reserve, and compensation
Montine, T. J., Cholerton, B. A., Corrada, M. M., Edland, S. D., Flanagan, M. E., Hemmy, L. S., Kawas, C. H., & White, L. R. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0479-y · Cited by 157 · cited 1×
“Additional terms that are relevant to this area are ‘resistance’ and ‘compensation’ [36].”
BackgroundDodge, H. H., Zhu, J., Mattek, N. C., Bowman, M., Ybarra, O., Wild, K. V., Loewenstein, D. A., & Kaye, J. A. (2015) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2015.01.001 · Cited by 129
Self-citationA roadmap to advance dementia research in prevention, diagnosis, intervention, and care by 2025
Pickett, J., Bird, C., Ballard, C., Banerjee, S., Brayne, C., Cowan, K., Clare, L., Comas‐Herrera, A., Corner, L., Daley, S., et al. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4868 · Cited by 113 · cited 1×
“The majority of the cohort studies from which risk factor data have been derived are now out of date, few are truly population representative, and there is little evidence for good comparison across different countries and between sub-groups within populations [29].”
BackgroundSelf-citationComputer-based cognitive training for older adults: Determinants of adherence
Turunen, M., Hokkanen, L., Bäckman, L., Stigsdotter-Neely, A., Hänninen, T., Paajanen, T., Soininen, H., Kivipelto, M., & Ngandu, T. (2019) · PLOS ONE · doi:10.1371/journal.pone.0219541 · Cited by 100 · cited 1×
“Multi-domain interventions will need to be evaluated not only for efficacy, but also for cost, participant burden, adherence [49] and practicality.”
BackgroundRisk Factors in Late Adolescence for Young-Onset Dementia in Men: A Nationwide Cohort Study
Nordström, P., Nordström, A., Eriksson, M., Wahlund, L.-O., & Gustafson, Y. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.9079 · Cited by 96 · cited 1×
“This means that alternative methods, such as case-control studies, large-scale register-based studies, and data pooling, may be required to obtain better information on risk factors associated with dementias such as frontotemporal [42], Lewy body dementia [43], limbic-predominant age-related TDP-43 encephalopathy [44]…”
MethodKane, M. D., Butler, P. D., & Fink, M. D. (2017) · doi:10.23970/ahrqepccer188 · Cited by 95 · cited 1×
“factors, increase in physical, mental, and social activity, and avoiding environmental hazards [16, 17].”
BackgroundRoestorf, A., Bowler, D. M., Deserno, M. K., Howlin, P., Klinger, L., McConachie, H., Parr, J. R., Powell, P., Van Heijst, B. F. C., & Geurts, H. M. (2019) · Research in Autism Spectrum Disorders · doi:10.1016/j.rasd.2018.08.007 · Cited by 87
Yang, L., Jin, X., Yan, J., Jin, Y., Yu, W., Wu, H., & Xu, S. (2016) · Age and Ageing · doi:10.1093/ageing/afw088 · Cited by 66
Factors Associated with the High Prevalence of Dementia in Older Aboriginal Australians
Radford, K. A., Lavrencic, L. M., Delbaere, K., Draper, B., Cumming, R. G., Daylight, G., Mack, H. A., Chalkley, S., Bennett, H. P., Garvey, G., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180573 · Cited by 62
Reversal of risk upon quitting smoking
Dresler, C. M., León, M. E., Straif, K., Baan, R., & Secretan, B. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69086-7 · Cited by 56 · cited 1×
“smoking where risk reversal has been extensively studied [33].”
BackgroundBott, N. T., Hall, A., Madero, E. N., Glenn, J. M., Fuseya, N., Gills, J. L., & Gray, M. (2019) · Nutrients · doi:10.3390/nu11092258 · Cited by 56 · cited 1×
“For example, leading multi-domain clinical trials such as FINGER, PreDIVA, and MYB, as well as other trials that are in development or in progress such as the US POINTER Trial, the MIND-China Trial, the SINGER Trial, CAN-THUMBS UP, HATICE, PRODEMOS, and SMARRT have been developed largely from evidence obtained in coho…”
BackgroundActive lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration
Casaletto, K. B., Staffaroni, A. M., Wolf, A., Appleby, B., Brushaber, D., Coppola, G., Dickerson, B., Domoto‐Reilly, K., Elahi, F. M., Fields, J., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12001 · Cited by 48
Self-citationDavis, J. W., Juarez, D. T., & Hodges, K. A. (2013) · PubMed · Cited by 43
Taylor, C., Tillin, T., Chaturvedi, N., Dewey, M., Ferri, C. P., Hughes, A., Prince, M., Richards, M., Shah, A., & Stewart, R. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12416 · Cited by 43
Implications of Risk Factors for Alzheimer’s Disease in Canada’s Indigenous Population
MacDonald, J. P., Barnes, D. E., & Middleton, L. E. (2015) · Canadian Geriatrics Journal · doi:10.5770/cgj.18.159 · Cited by 41 · cited 2×
“Within countries and cohort studies it is possible that risk exposure, risk effects and protective mechanisms (e.g., cognitive resilience, cognitive reserve, coping mechanisms and strategies) vary within subgroups (e.g., indigenous populations in Australia [24], Canada and United States [25]; racial minorities in the…”
BackgroundSelf-citationAnstey, K. J., Peters, R., Clare, L., Lautenschlager, N. T., Dodge, H. H., Barnes, D. E., Shahar, S., Brodaty, H., & Rees, G. (2017) · International Psychogeriatrics · doi:10.1017/s1041610217001685 · Cited by 36 · cited 10×
“At our first international conference in October 2019, the IRNDP leadership committee held a workshop of experts to develop a position paper on future directions for research on dementia prevention and dementia risk reduction.”
BackgroundInfluentialSelf-citationSapkota, S., Huan, T., Tran, T., Zheng, J., Camicioli, R., Li, L., & Dixon, R. A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00296 · Cited by 35 · cited 1×
“Similarly, data from observational studies could be used to evaluate interactions or joint effects of risk factor combinations [31].”
MethodSelf-citationSystematic reviews and research waste
Chalmers, I., & Glasziou, P. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01353-7 · Cited by 32
Javanshiri, K., Haglund, M., & Englund, E. M. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190485 · Cited by 27 · cited 1×
“This means that alternative methods, such as case-control studies, large-scale register-based studies, and data pooling, may be required to obtain better information on risk factors associated with dementias such as frontotemporal [42], Lewy body dementia [43], limbic-predominant age-related TDP-43 encephalopathy [44]…”
MethodGlymour, M. M., & Whitmer, R. A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190304 · Cited by 26
Kiejna, A., Frydecka, D., Adamowski, T., Bickel, H., Reynish, E., Prince, M., Caracciolo, B., Fratiglioni, L., & Georges, J. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2511 · Cited by 25 · cited 1×
“Within Europe, there is a lack of epidemiological data from Eastern and Middle European countries [23].”
BackgroundPopulation-Based Approaches to Dementia Prevention
Sexton, C. E., & Yaffe, K. S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190104 · Cited by 9
Self-citationPrevention of Cognitive Decline: A Goal in Sight?
Brayne, C., & Richard, E. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190448 · Cited by 9
Self-citationGustafson, D. (2018) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2018/5.1220 · Cited by 9 · cited 1×
“, [40]) and there is a lack of risk reduction trials that specify dementia driven by vascular pathology as a primary or secondary outcome [41].”
Background
Research works printed but not linked: 1
- National Academies of Sciences, Engineering, and Medicine (2017) Preventing Cognitive Decline and Dementia: A Way Forward, The National Academies Press, Washington, DC.
Cited by
Frisoni, G. B., Altomare, D., Ribaldi, F., Villain, N., Brayne, C., Mukadam, N., Abramowicz, M., Barkhof, F., Berthier, M., Bieler-Aeschlimann, M., et al. (2023) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2022.100576 · Cited by 186
Self-citationAssociation between metabolic syndrome and risk of incident dementia in UK Biobank
Qureshi, D., Collister, J. A., Allen, N. E., Kuźma, E., & Littlejohns, T. J. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13439 · Cited by 131
“71 Inourstudy, we found that only some MetS combinations were associated with dementia risk.”
Alzheimer’s Disease and Inflammaging
Kosyreva, A., Sentyabreva, A., Tsvetkov, I., & Makarova, O. (2022) · Brain Sciences · doi:10.3390/brainsci12091237 · Cited by 98
Umbrella review and Delphi study on modifiable factors for dementia risk reduction
Rosenau, C., Köhler, S., Soons, L. M., Anstey, K. J., Brayne, C., Brodaty, H., Engedal, K., Farina, F. R., Ganguli, M., Livingston, G., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13577 · Cited by 74
“127,128 Despitetheratherconsistentobservationalevidenceforthefactors highlighted in the current study, the evidence from RCTs intervening on these factors is limited.”
BackgroundSelf-citationBartlett, L., Doherty, K., Farrow, M., Kim, S., Hill, E., King, A. E., Alty, J., Eccleston, C. E. A., Kitsos, A., Bindoff, A. D., et al. (2021) · JMIR Research Protocols · doi:10.2196/34688 · Cited by 51
“The overall objective of the project is to extend and translate epidemiological and experimental intervention evidence regarding modifiable dementia risk factors, integrate life-course perspectives and inform policy development for public health dementia risk reduction initiatives [9,10].”
Metadata
- Authors
- Anstey, K. J., Peters, R., Zheng, L., Barnes, D. E., Brayne, C., Brodaty, H., Chalmers, J., Clare, L., Dixon, R. A., Dodge, H., Lautenschlager, N. T., Middleton, L. E., Qiu, C., Rees, G., Shahar, S., & Yaffe, K.
- Affiliations
- UNSW Sydney (AU)
- San Francisco VA Medical Center (US)
- University of Cambridge (GB)
- University of Exeter (GB)
- University of Alberta (CA)
- Oregon Health & Science University (US)
- The Royal Melbourne Hospital (AU)
- University of Waterloo (CA)
- Karolinska Institutet (SE)
- Alzheimer Disease International (GB)
- National University of Malaysia (MY)
- Corresponding author
- Anstey, Kaarin J.
- ORCID
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2020-10-27
- Volume
- 78
- Issue
- 1
- Pages
- 3-12
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC7609069
- OpenAlex
- W3086434969
- Cited by
- 40
- References
- 46
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 9 · 2023: 7 · 2022: 6 · 2021: 8
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- UNSWorks (UNSW Sydney) (submittedVersion, cc-by-nc-nd)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc)
- Funders
- Australian Government
- Swedish Foundation for International Cooperation in Research and Higher Education (CH2019-8320)
- Karolinska Institutet
- Vetenskapsrådet (2017-05819, 2017-00740)
- National Health and Medical Research Council (1102694)
- National Institute on Aging (P30AG008017, R01AG051628, P30AG066518)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- dementia prevention, dementia risk factors
- MeSH terms
- Dementia, Europe, Humans, North America, Risk Factors, Consensus, Biomedical Research, Risk Reduction Behavior
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.